Skip to main content
Livermore
Livermore
ZHEN

Tobam

SEC CIK
0001527488
Latest filing
Jul 31, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Tobam, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,364
Value
$678.0K
% of portfolio
0.2%
Quarters held
21
Since Q1 2021
Holdings of VRTX by Tobam, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,364$678.0K0.2%+105+8.3%AddedHolders
Q1 20261,259$562.0K0.1%+105+9.1%AddedHolders
Q4 20251,154$523.0K0.1%+1,154NewHolders
Q3 20250$00.0%−3−100.0%Sold outHolders
Q2 20253$1.00K<0.1%00.0%UnchangedHolders
Q1 20253$1.00K<0.1%−361−99.2%ReducedHolders
Q4 2024364$147.0K<0.1%−117−24.3%ReducedHolders
Q3 2024481$224.0K<0.1%−144−23.0%ReducedHolders
Q2 2024625$293.0K<0.1%−1,358−68.5%ReducedHolders
Q1 20241,983$829.0K0.1%−88−4.2%ReducedHolders
Q4 20232,071$843.0K0.1%−826−28.5%ReducedHolders
Q3 20232,897$1.01M0.1%−324−10.1%ReducedHolders
Q2 20233,221$1.13M0.1%00.0%UnchangedHolders
Q1 20233,221$1.01M0.1%00.0%UnchangedHolders
Q4 20223,221$930.0K0.1%−138−4.1%ReducedHolders
Q3 20223,359$973.0K0.1%−13,701−80.3%ReducedHolders
Q2 202217,060$4.81M0.3%−16,067−48.5%ReducedHolders
Q1 202233,127$8.64M0.4%+27,114+450.9%AddedHolders
Q4 20216,013$1.32M0.1%+381+6.8%AddedHolders
Q3 20215,632$1.02M<0.1%+4,739+530.7%AddedHolders
Q2 2021893$180.0K<0.1%00.0%UnchangedHolders
Q1 2021893$192.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.